Analyst Coverage
Analyst Coverage
The following research analysts cover Destiny Pharma.
Mark Brewer, finnCap | +44(0)20 7220 0500 |
Andy Smith, Equity Development | +44(0)20 7065 2690 |
Please click on links below to access coverage published:
![]() |
finnCap
Analyst research from finnCap can be obtained by registering on the link above 17 September 2020 – Interims – on track for Q1 2021 Phase 2b readout 7 September 2020 – Co-development collaboration and Innovate UK grant |
![]() |
Equity Development
11 December 2020 – Interview with Neil Clark, CEO 27 November 2020 – Competition for XF-73 moves aside, issue approved |
![]() |
Proactive Investors
For further commentary and interviews, please visit the Destiny Pharma page at Proactive Investors on the link above |